IGF1R and hepatocellular carcinoma: Currently, there are three studies on the mechanism of miR-592 in HCC, in which the downstream consists of IGF-1R (Wang et al., 2017b), WSB1 (Jia et al., 2016), and DEK (Li et al., 2015).